Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 4.76 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $153.208 million which missed the analyst consensus estimate of $155.640 million by 1.56 percent. This is a 3.76 percent increase over sales of $147.660 million the same period last year.